Inactivation of dihydropteridine reductase (human brain) by platinum(II) complexes

Eur J Biochem. 1987 Apr 15;164(2):403-9. doi: 10.1111/j.1432-1033.1987.tb11072.x.

Abstract

Potassium tetrachloroplatinate (K2PtCl4) inactivates dihydropteridine reductase from human brain in a time-dependent and irreversible manner. The inactivation has been followed by measuring enzyme activity and fluorescence changes. The enzyme is completely protected from inactivation by NADH, the pterin cofactor [quinonoid 6-methyl-7,8-dihydro(6H)pterin] and dithiothreitol. Evidence is presented that K2PtCl4 reacts at the active site and that (a) thiol group(s) is involved in, or is masked by, this reaction. K2PtCl4 is a stronger inhibitor of human brain dihydropteridine reductase that cis- and trans-diaminodichloroplatinum, cis-dichloro[ethylenediamine]platinum and K4Fe(CN)6, whereas H2PtCl6 is considerably weaker and (Ph3P)3RhCl is inactive.

MeSH terms

  • Binding Sites
  • Brain / enzymology
  • Chlorides / pharmacology
  • Cisplatin / pharmacology
  • Dihydropteridine Reductase / antagonists & inhibitors*
  • Humans
  • In Vitro Techniques
  • Kinetics
  • NADH, NADPH Oxidoreductases / antagonists & inhibitors*
  • Organoplatinum Compounds / pharmacology
  • Platinum / pharmacology*
  • Platinum Compounds*
  • Protein Conformation
  • Spectrometry, Fluorescence
  • Sulfhydryl Compounds

Substances

  • Chlorides
  • Organoplatinum Compounds
  • Platinum Compounds
  • Sulfhydryl Compounds
  • tetrachloroplatinate
  • platinum ethylenediamine dichloride
  • transplatin
  • Platinum
  • Dihydropteridine Reductase
  • NADH, NADPH Oxidoreductases
  • Cisplatin